C12Y 301/01013
Sterol esterase
Official title: Sterol esterase (3.1.1.13)
C12Y301/01013 (Sterol esterase) appears on 25 US grants and 55 published applications in this corpus.
Search patents in C12Y- Granted patents
- 25
- Published applications
- 55
- Assignees
- 33
- Inventors
- 113
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 2 |
| 2014 | 1 | 2 |
| 2015 | 1 | 4 |
| 2016 | 0 | 2 |
| 2017 | 0 | 4 |
| 2018 | 0 | 0 |
| 2019 | 2 | 6 |
| 2020 | 3 | 3 |
| 2021 | 1 | 6 |
| 2022 | 4 | 8 |
| 2023 | 1 | 3 |
| 2024 | 4 | 3 |
| 2025 | 1 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Microorganism having enhanced L-threonine producing ability and method for producing threonine using the same28 Jul 2026US 12,692,522 B2Cj Cheiljedang Corporation
- Methods for the production of ferulic acid12 Aug 2025US 12,385,071 B2Inventure Renewables, Inc.
- Modified mammalian cells24 Sep 2024US 12,098,365 B2Genentech, Inc.
- Methods for treating lysosomal acid lipase deficiency in patients3 Sep 2024US 12,076,376 B2Alexion Pharmaceuticals, Inc.
- Methods and compositions for treatment of cholesteryl ester storage disease13 Aug 2024US 12,060,558 B2Stoke Therapeutics, Inc.
- Modified mammalian cells9 Apr 2026US 2026/0098254 A1Genentech, Inc.
- Reagent composition and kit23 Oct 2025US 2025/0327111 A1Denka Company Limited
- Antibacterial polypeptides4 Sep 2025US 2025/0276035 A1Novalysin AB
- Modified mammalian cells27 Mar 2025US 2025/0101411 A1Genentech, Inc.
- Methods for treating lysosomal acid lipase deficiency in patients23 Jan 2025US 2025/0025538 A1Alexion Pharmaceuticals, Inc.
Most cited
By later US patents
- Mammalian pancreatic cholesterol esterase19US 5,173,408 A1992
- Methods for treating lysosomal acid lipase deficiency in patients12US 8,663,631 B2Synageva BioPharma Corp. · 2014
- Lipid hydrolysis therapy for atherosclerosis and related diseases11US 6,849,257 B2Children's Hospital Research Foundation · 2005
- Methods for treating lysosomal acid lipase deficiency in patients3US 10,166,274 B2Alexion Pharmaceuticals, Inc. · 2019
- Lysosomal storage disease enzymes2US 10,407,671 B2Alexion Pharmaceuticals, Inc. · 2019